# PTC Therapeutics, Inc. (PTCT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PTCT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 633.07M | $ 80.69M | $ 61.57M | $ 696.47M | $ -165.36M |
| 2025 | $ 1.77B | $ 698.97M | $ 421.02M | $ 2.71B | $ -205.31M |
| 2024 | $ 847.99M | $ -381.85M | $ -191.23M | $ 2.47B | $ -1.10B |
| 2023 | $ 1.01B | $ -677.52M | $ -301.71M | $ 2.23B | $ -818.56M |
| 2022 | $ 780.63M | $ -624.48M | $ -568.73M | $ 1.46B | $ -347.09M |
| 2021 | $ 640.20M | $ -622.74M | $ -400.18M | $ 1.27B | $ 1.44M |
| 2020 | $ 485.07M | $ -558.19M | $ -330.02M | $ 420.44M | $ 481.98M |
| 2019 | $ 396.23M | $ -324.72M | $ -185.97M | $ 328.03M | $ 594.33M |
| 2018 | $ 349.63M | $ -169.16M | $ -57.02M | $ 153.01M | $ 350.73M |
| 2017 | $ 261.87M | $ -106.42M | $ -17.73M | $ 144.97M | $ 156.44M |
| 2016 | $ 113.79M | $ -195.52M | $ -144.93M | $ 98.22M | $ 119.58M |
| 2015 | $ 48.13M | $ -239.31M | $ -178.39M | $ 94.61M | $ 298.47M |
| 2014 | $ 32.45M | $ -132.47M | $ -87.52M | $ 0 | $ 298.47M |
| 2013 | $ 44.55M | $ -73.35M | $ -67.94M | $ 48.6K | $ 136.54M |
| 2012 | $ 41.55M | $ -37.88M | $ -69.47M | $ 4.88M | $ -19.19M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -4.21 |
| Liabilities / Eq | -20.66 |
| Current Ratio | 3.39 |

## Other views

- [Metrics](https://sponda.capital/en/PTCT.md)
- [Charts](https://sponda.capital/en/PTCT/charts.md)
- [Compare](https://sponda.capital/en/PTCT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-28.